Collectively, these findings demonstrate that a loss of Tdg leads to a dysregulation in the FXR-SHP axis in the liver and that TdgcKO mice exhibit an increased prevalence of HCC in a background of elevated serum and intrahepatic BAs. This evidence concerns the gene TDG and hepatocellular carcinoma.